MBI-HMany Bright Ideas Technologies Inc.
0.0300CAD0.00%Mkt Cap: 314205 $P/E: Infinity

Many Bright Ideas Technologies Inc. does not have significant operations. Previously, the company was involved in the life science business with a focus on the commercialization of prognostic genomic-based tests for non-…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$213.32BUSDP/E 30.8
DHR
Danaher Corporation
$138.84BUSDP/E 35.1
LONN
Lonza Group AG
$44.66BUSDP/E 36.1
IDXX
IDEXX Laboratories, Inc.
$44.79BUSDP/E 41.8
A
Agilent Technologies, Inc.
$39.48BUSDP/E 28.1
NTRA
Natera, Inc.
$38.72BUSD
IQV
IQVIA Holdings Inc.
$38.41BUSDP/E 29.0
WAT
Waters Corporation
$36.79BUSDP/E 47.7
ILMN
Illumina, Inc.
$29.98BUSDP/E 37.0
MTD
Mettler-Toledo International Inc.
$29.20BUSDP/E 32.6
DGX
Quest Diagnostics Incorporated
$25.60BUSDP/E 24.6
LH
Labcorp Holdings Inc.
$24.87BUSDP/E 25.4
GH
Guardant Health, Inc.
$21.31BUSD
MEDP
Medpace Holdings, Inc.
$16.00BUSDP/E 33.7
ERF
Eurofins Scientific SE
$12.72BUSDP/E 23.5
RVTY
Revvity, Inc.
$12.85BUSDP/E 55.4
CRL
Charles River Laboratories International, Inc.
$11.12BUSD
BIM
bioMérieux S.A.
$9.26BUSDP/E 18.5
BLLN
BillionToOne, Inc.
$6.32BUSDP/E 254.3
TWST
Twist Bioscience Corporation
$6.29BUSD
RDNT
RadNet, Inc.
$5.25BUSD
SHC
Sotera Health Company
$5.13BUSDP/E 43.9
DIA
DiaSorin S.p.A.
$4.04BUSDP/E 28.5
ADPT
Adaptive Biotechnologies Corporation
$3.68BUSD
VCYT
Veracyte, Inc.
$3.58BUSDP/E 32.0
GRAL
GRAIL, Inc.
$3.02BUSD
CDNA
CareDx, Inc.
$2.48BUSDP/E 23.0
NEO
NeoGenomics, Inc.
$2.06BUSD
WGS
GeneDx Holdings Corp.
$2.01BUSD
VIMIAN
Vimian Group AB (publ)
$1.76BUSDP/E 45.1
DIA
Diagnostyka S.A.
$1.43BUSDP/E 21.7
PSNL
Personalis, Inc.
$1.41BUSD
FRNM
Freenome, Inc.
$1.17BUSD
CBAV
Clínica Baviera, S.A.
$1.06BUSDP/E 21.2
OPK
OPKO Health, Inc.
$977.69MUSD
CSTL
Castle Biosciences, Inc.
$928.40MUSD
LBIRD
Lumibird SA
$639.18MUSDP/E 41.6
FLGT
Fulgent Genetics, Inc.
$500.14MUSD
VOX
Voxel S.A.
$335.15MUSDP/E 3.4
EDT
Spectral Medical Inc.
$297.02MUSD
MYGN
Myriad Genetics, Inc.
$285.23MUSD
BDSX
Biodesix, Inc.
$228.14MUSD
IMDX
Insight Molecular Diagnostics Inc.
$162.42MUSD
SLV
Selvita S.A.
$129.44MUSD
XGN
Exagen Inc.
$113.07MUSD
SCP
Scope Fluidics S.A.
$94.84MUSD
ALECR
Eurofins-Cerep SA
$89.37MUSDP/E 17.2
BIOPOR
BioPorto A/S
$85.81MUSD
PANG
Pangaea Oncology, S.A.
$60.51MUSD
BUX
Biomark Diagnostics Inc.
$42.86MUSD
PRPO
Precipio, Inc.
$39.55MUSD
ABDX
Abingdon Health Plc
$28.66MUSD
NN6
NanoRepro AG
$28.11MUSD
GDR
genedrive plc
$17.45MUSD
SENZA
SenzaGen AB
$16.29MUSD
IMMNOV
Immunovia AB (publ)
$11.90MUSD
IZO
Izotropic Corporation
$12.56MUSD
BMX
BioMaxima S.A.
$10.53MUSD
XWEL
XWELL, Inc.
$9.20MUSD
PRM
Proteome Sciences plc
$6.86MUSD
VRCI
Verici Dx plc
$5.59MUSD
ALPRE
Predilife S.A.
$5.14MUSD
OBD
Oxford BioDynamics Plc
$5.13MUSD
NDRA
ENDRA Life Sciences Inc.
$5.31MUSD
AVCR
Avricore Health Inc.
$5.06MUSD
JUMP
Leveljump Healthcare Corp.
$4.44MUSD
BIAF
bioAffinity Technologies, Inc.
$3.75MUSD
TELO
Telo Genomics Corp.
$3.29MUSD
PROGEN
Prostatype Genomics AB (publ)
$2.67MUSD
ISPC
iSpecimen Inc.
$2.89MUSD
PRPH
ProPhase Labs, Inc.
$434.5KUSD
TTOO
T2 Biosystems, Inc.
$14.0KUSD
Indicators:|

Key Statistics

Company
Market Cap314.20K $
Enterprise Value451.73K $
Revenue (TTM)
Gross Profit
Net Income (TTM)-33.86K $
Revenue/Share
Last Price0.0300 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees
CountryCA
SectorHealthcare
IndustryDiagnostics & Research
ISIN
Valuation
P/E (Trailing)Infinity
P/E (Forward)
PEG
EV/EBITDA
EV/Revenue
P/S
P/B-1.36
EPS (TTM)0.00
EPS (Forward)
52W Range
0.020033% of range0.0500
52W High0.0500 CAD
52W Low0.0200 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE20.75%
ROA-2088.63%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-32.23K $
CapEx (TTM)
FCF Margin
FCF Yield-37.60%
Net Debt137.53K $
Net Debt/EBITDA
Balance Sheet
Debt/Equity
Current Ratio0.04
Quick Ratio0.00
Book Value/Sh-0.0183 CAD
Cash/Share0.0000 CAD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 CAD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay DateDec 19, 2017
Splits
Last Split1:10
Split DateDec 19, 2017
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.17.26M
Float9.43M
Insiders49.22%
Institutions0.00%
Short Interest
Short % Out.0.00%
Shares Short403
Short (prev mo.)403
Technical
SMA 500.0300 (-0.0%)
SMA 2000.0256 (+17.2%)
Beta1.57
S&P 52W Chg18.32%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)99.9
MACD0.0001
MACD Signal0.0002
MACD Hist.-0.0001
BB Upper0.0300 CAD
BB Middle0.0300 CAD
BB Lower0.0300 CAD
BB Width0.00%
ATR (14)0.0000 CAD
Vol Ratio (20d)